Michael Verzi Appointed to the Duncan and Nancy MacMillan Endowed Chair in Cancer Genomics
The Rutgers University Board of Governors has appointed Michael Verzi to the Duncan and Nancy MacMillan Endowed Chair in Cancer Genomics for a five-year renewable term, commencing July 1, 2023.
An internationally recognized researcher in the field of colon and intestinal cancer, Verzi’s work is published in leading cancer research journals and holds strong support from major funding agencies, including the National Institutes of Health and American Cancer Society. The 2021-2022 Board of Trustees Award for Excellence in Research and the SAS 2019-2020 Award for Distinguished Contributions to Undergraduate Education celebrated his accomplishments in research and teaching.
A professor in the Department of Genetics in The School of Arts and Sciences, Verzi’s Lab of Gastrointestinal Research pursues studies on the development and function of the normal intestine, intestinal stem cells, the role of cellular metabolism in intestinal health and inflammatory bowel diseases and colorectal cancers.
Prior to his arrival at Rutgers in the fall of 2011, Verzi served as research scientist at the Dana-Farber Cancer Institute. He earned his Ph.D. in biochemistry and developmental biology from the University of California, San Francisco, in 2005.
The Duncan and Nancy MacMillan Endowed Chair in Cancer Genomics was established in 2016 to enhance the understanding of the mechanisms of cancer and help lead to improvements in the prevention, detection, diagnosis and treatment of cancer.
